Inotuzumab ozogamicin Intravenous and Pms-Sodium Polystyrene Sulfonate
Determining the interaction of Inotuzumab ozogamicin Intravenous and Pms-Sodium Polystyrene Sulfonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotuzumab ozogamicin Intravenous-Pneumococcal 13-valent conjugate vaccine
- Inotuzumab ozogamicin Intravenous-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Inotuzumab ozogamicin Intravenous-Pneumococcal Conjugate Vaccine (13-Valent)
- Inotuzumab ozogamicin Intravenous-Pneumococcal Conjugate Vaccine (7-Valent)
- Inotuzumab ozogamicin Intravenous-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Inotuzumab ozogamicin Intravenous-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pms-Sodium Polystyrene Sulfonate-Inova
- Pms-Sodium Polystyrene Sulfonate-Inova 4/1 topical
- Pms-Sodium Polystyrene Sulfonate-Inova 8/2 topical
- Pms-Sodium Polystyrene Sulfonate-Inova ACT
- Pms-Sodium Polystyrene Sulfonate-Inrebic
- Pms-Sodium Polystyrene Sulfonate-Inspra